Wicab
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Wicab - overview
Location
Middleton, WI, US
Primary Industry
Medical Devices & Equipment
About
Wicab develops innovative assistive technologies aimed at enhancing sensory perception, primarily focusing on products that aid those with visual impairments and balance disorders. Wicab is dedicated to creating assistive technology solutions for individuals facing sensory challenges. The company is headquartered in Middleton, US. Robert Beckman leads Wicab as CEO.
In 2014, the company secured USD 3 million in funding from Haiyin Capital, marking its singular deal to date. This funding was aimed at supporting its ongoing product development and expansion initiatives. Wicab specializes in innovative assistive technologies, featuring two main products: the BrainPort Vision Pro and the BrainPort Balance Plus. The BrainPort Vision Pro offers visual perception to profoundly blind individuals by converting visual data into tactile sensations on the tongue.
The BrainPort Balance Plus provides biofeedback balance training, helping users improve stability and decrease fall risks. These technologies are marketed mainly in North America and Europe, targeting healthcare providers, rehabilitation centers, and individuals requiring enhanced sensory support. Wicab generates revenue through direct sales of its flagship products to healthcare facilities and individual consumers. The BrainPort Vision Pro and BrainPort Balance Plus are sold directly to consumers and through partnerships with medical professionals and rehabilitation centers, ensuring comprehensive usage support and training.
The pricing reflects the specialized nature of these products, aimed at delivering value to those dealing with significant health challenges, supported by ongoing customer service and engagement initiatives. Wicab aims to further develop its product line, specifically working on upcoming enhancements to the BrainPort technologies. The company plans to penetrate new markets in Europe and Asia by the end of 2015, leveraging the USD 3 million funding from its 2014 investment to facilitate these expansions. This capital will be utilized for product development and market entry strategies, ensuring Wicab can effectively meet the needs of users worldwide.
Current Investors
Haiyin Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.wicab.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.